The Effect of Adding Nalbuphine to Intrathecal Morphine on Analgesic Efficacy and Side Effects After Cesarean Section

Last updated: December 24, 2017
Sponsor: Abdelrady S Ibrahim, MD
Overall Status: Completed

Phase

2

Condition

Chronic Pain

Pain

Post-surgical Pain

Treatment

N/A

Clinical Study ID

NCT02716129
IRB0000871235
  • Ages 18-40
  • Female

Study Summary

The primary endpoint of this study is to investigate the effect of adding nalbuphine to intrathecal morphine on quality of postoperative analgesia and Morphine related side effects post- cesarean delivery.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Female patients

  • age between 16 to 40 years

  • ASA physical status I - II

Exclusion

Exclusion Criteria:

  • Infection at the site of injection.

  • Coagulopathy or other bleeding diathesis.

  • Preexisting neurologic deficits.

  • History of hypersensitivity to any of the given the drugs.

  • Inability to communicate with the investigator and the hospital staff.

  • History of chronic opioid us

Study Design

Total Participants: 80
Study Start date:
July 01, 2016
Estimated Completion Date:
October 31, 2017

Study Description

The study will be performed in Assiut University Hospitals, after obtaining approval from the local ethics committee and written informed patient consent. All patients will have a peripheral IV cannula 18 G inserted; standard non-invasive monitors will be applied. All the patients will be preloaded with 10 ml/kg Ringer's lactate solution intravenous. Intrathecal block under strict aseptic conditions will be performed in sitting position at L3-4 or L4-5 inter-spinous space with 25G pencil-point spinal needle. All patients will receive intrathecal 10 mg of 0.5% hyperbaric bupivacaine.

Connect with a study center

  • Assiut university faculty of medicine

    Assiut,
    Egypt

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.